Kawasaki disease
Conditions
Interventions
None listed
Sponsors
Chiba Cancer Center Research Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Information on the children delivered via CS or VD and their mothers was collected from all periods in the database. CS was performed using a procedure detected using Japanese medical procedure codes.Herein, the primary outcome was defined as KD occurrence based on specific criteria. Specifically, we included patients diagnosed with KD (ICD-10 code M303) who had received intravenous immunoglobulin treatment.
Exclusion criteria
Exclusion criteria: Cases labeled as suspected were excluded, whereas those with atypical KD were included. Considering the importance of an accurate diagnosis in this study, we excluded patients more than 6 years of age because this is not the typical age of KD onset, and distinguishing KD from other diseases in this age group is challenging.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients with KD were identified from the source population. Subsequently, in every case, we randomly selected controls with no KD history based on a risk-set sampling technique. Each patient was matched to four controls of the same sex, age, and registration time in the database. We subsequently examined the association between the delivery type and KD onset using multivariate conditional logistic regression analysis.We defined the primary outcome as KD, based on specific criteria. | — |
Countries
Japan
Contacts
Public ContactTakanori Suzuki
Fujita health university Pediatrics
Outcome results
None listed